Evidence map›Paper›PMID 28525587›Full record

ArticleThe international journal of neuropsychopharmacology2017

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Frederic Sampedro, Mario de la Fuente Revenga, Marta Valle, Natalia Roberto, Elisabet Domínguez-Clavé, Matilde Elices, Luís Eduardo Luna, José Alexandre S Crippa, Jaime E C Hallak, Draulio B de Araujo and 7 more

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it, 199 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023
    Pooled it
  4. The pharmacological interaction of compounds in ayahuasca: a systematic review.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Effective connectivity changes in LSD-induced altered states of consciousness in humans.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Trial
  12. Trial
  13. Review
  14. Article
  15. Learning as the unifying mechanism of psychedelic action.Journal of psychopharmacology (Oxford, England) · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Frederic SampedroSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Mario de la Fuente RevengaSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Marta ValleSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Natalia RobertoSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Elisabet Domínguez-ClavéSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Matilde ElicesSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Luís Eduardo LunaSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
José Alexandre S CrippaSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Jaime E C HallakSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Draulio B de AraujoSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Pablo FriedlanderSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Steven A BarkerSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Enrique ÁlvarezSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Joaquim SolerSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Juan C PascualSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Amanda FeildingSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Jordi RibaSchool of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Human Neuropsychopharmacology Research Group, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Pharmacokinetic and Pharmacodynamic Modelling and Simulation, Sant Pau Institute of Biomedical Research, Barcelona, Spain; Centre d'Investigació de Medicaments, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain; Department of Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain; Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Research Center for the Study of Psychointegrator Plants, Visionary Art and Consciousness, Florianópolis, Santa Catarina, Brazil; Department of Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil and National Institute for Translational Medicine, Ribeirão Preto, Brazil; Brain Institute/Hospital Universitario Onofre Lopes, Natal, Brazil; The Beckley Foundation, Beckley Park, Oxford, United Kingdom; Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive at River Road, Baton Rouge, Louisiana; Department of Clinical and Health Psychology, School of Psychology, Autonomous University of Barcelona, Barcelona, Spain.
Hospital de Sant Pau · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures. Methods: Using 1H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose. Results: Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later. Conclusions: These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.

Indexed as

MindfulnessAdultAspartic AcidBanisteriopsisBrain MappingCerebral CortexFemaleFollow-Up StudiesGlutamic AcidHallucinogensHealthy VolunteersHumansImaging, Three-DimensionalMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleAspartic AcidGlutamic AcidHallucinogensN-acetylaspartateayahuascahumanmagnetic resonance imagingmindfulnesspsychedelic after-effects

Identifiers

PMID28525587
PMCPMC5581489
OpenAlexW2616273018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.